Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Chromosome 20p11 gains are associated with liver-specific metastasis in patients with colorectal cancer.
Mekenkamp LJ, Haan JC, Koopman M, Vink-Börger ME, Israeli D, Teerenstra S, Ylstra B, Meijer GA, Punt CJ, Nagtegaal ID.
Gut. 2012 Jan 20. [Epub ahead of print]
Related citations
ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis.
Agesen TH, Sveen A, Merok MA, Lind GE, Nesbakken A, Skotheim RI, Lothe RA.
Gut. 2012 Jan 2. [Epub ahead of print]
Performance measures in three rounds of the English bowel cancer screening pilot.
Moss SM, Campbell C, Melia J, Coleman D, Smith S, Parker R, Ramsell P, Patnick J, Weller DP.
Gut. 2012 Jan;61(1):101-7. Epub 2011 May 10.
Limited effect of summer warming on the sensitivity of colorectal cancer screening.
Zorzi M, Baracco S, Fedato C.
Gut. 2012 Jan;61(1):162; author reply 162. Epub 2010 Dec 29. No abstract available.
Suppression of tumour-specific CD4+ T cells by regulatory T cells is associated with progression of human colorectal cancer.
Betts G, Jones E, Junaid S, El-Shanawany T, Scurr M, Mizen P, Kumar M, Jones S, Rees B, Williams G, Gallimore A, Godkin A.
Gut. 2011 Dec 29. [Epub ahead of print]
Burden of colonoscopy compared to non-cathartic CT-colonography in a colorectal cancer screening programme: randomised controlled trial.
de Wijkerslooth TR, de Haan MC, Stoop EM, Bossuyt PM, Thomeer M, Essink-Bot ML, van Leerdam ME, Fockens P, Kuipers EJ, Stoker J, Dekker E.
Gut. 2011 Dec 23. [Epub ahead of print]
5-aminosalicylic acid inhibits cell cycle progression in a phospholipase D dependent manner in colorectal cancer.
Baan B, Dihal AA, Hoff E, Bos CL, Voorneveld PW, Koelink PJ, Wildenberg ME, Muncan V, Heijmans J, Verspaget HW, Richel DJ, Hardwick JC, Hommes DW, Peppelenbosch MP, van den Brink GR.
Gut. 2011 Dec 20. [Epub ahead of print]
An alternative way for epithelial-to-mesenchymal transition in colorectal cancer via EIF5A2?
Kolligs FT.
Gut. 2012 Apr;61(4):473-4. Epub 2011 Dec 16. No abstract available.
Interleukin 21 controls tumour growth and tumour immunosurveillance in colitis-associated tumorigenesis in mice.
Jauch D, Martin M, Schiechl G, Kesselring R, Schlitt HJ, Geissler EK, Fichtner-Feigl S.
Gut. 2011 Dec;60(12):1678-86. Epub 2011 Sep 23.
Maternal B vitamin supplementation from preconception through weaning suppresses intestinal tumorigenesis in Apc1638N mouse offspring.
Ciappio ED, Liu Z, Brooks RS, Mason JB, Bronson RT, Crott JW.
Gut. 2011 Dec;60(12):1695-702. Epub 2011 Jun 9.
Electronic nose versus canine nose: clash of the titans.
Arasaradnam RP, Nwokolo CU, Bardhan KD, Covington JA.
Gut. 2011 Dec;60(12):1768. Epub 2011 Mar 24. No abstract available.
CT colonography for detection and characterisation of synchronous proximal colonic lesions in patients with stenosing colorectal cancer.
Park SH, Lee JH, Lee SS, Kim JC, Yu CS, Kim HC, Ye BD, Kim MJ, Kim AY, Ha HK.
Gut. 2011 Nov 23. [Epub ahead of print]
Long-term risk of colorectal cancer after adenoma removal: a population-based cohort study.
Cottet V, Jooste V, Fournel I, Bouvier AM, Faivre J, Bonithon-Kopp C.
Gut. 2011 Nov 22. [Epub ahead of print]
Clinical application of a systems model of apoptosis execution for the prediction of colorectal cancer therapy responses and personalisation of therapy.
Hector S, Rehm M, Schmid J, Kehoe J, McCawley N, Dicker P, Murray F, McNamara D, Kay EW, Concannon CG, Huber HJ, Prehn JH.
Gut. 2012 May;61(5):725-33. Epub 2011 Nov 14.
Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up.
Scholefield JH, Moss SM, Mangham CM, Whynes DK, Hardcastle JD.
Gut. 2012 Jul;61(7):1036-40. Epub 2011 Nov 3.
miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer.
Ma Y, Zhang P, Wang F, Zhang H, Yang J, Peng J, Liu W, Qin H.
Gut. 2011 Nov 3. [Epub ahead of print]
Five-year risk for advanced colorectal neoplasia after initial colonoscopy according to the baseline risk stratification: a prospective study in 2452 asymptomatic Koreans.
Chung SJ, Kim YS, Yang SY, Song JH, Kim D, Park MJ, Kim SG, Song IS, Kim JS.
Gut. 2011 Nov;60(11):1537-43. Epub 2011 Mar 22.
Ascl2 and 11p15.5 amplification in colorectal cancer.
Jubb AM, Hoeflich KP, Haverty PM, Wang J, Koeppen H.
Gut. 2011 Nov;60(11):1606-7; author reply 1607. Epub 2010 Nov 23. No abstract available.
Error occurred: cannot get document summary
Postmenopausal hormone therapy and colorectal cancer risk by molecularly defined subtypes among older women.
Limsui D, Vierkant RA, Tillmans LS, Wang AH, Weisenberger DJ, Laird PW, Lynch CF, Anderson KE, French AJ, Haile RW, Harnack LJ, Potter JD, Slager SL, Smyrk TC, Thibodeau SN, Cerhan JR, Limburg PJ.
Gut. 2011 Oct 24. [Epub ahead of print]
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on